Sanofi India Limited — Others, 16-07-2025: Change in Management

Sanofi India's board approved key strategic and leadership changes. Rachid Ayari, the Chief Financial Officer, has been appointed Interim Managing Director for a six-month term, ensuring leadership continuity. Additionally, Aniket Raje was named Head of Regulatory Affairs. In a significant business move, the company forged an exclusive five-year distribution and promotion agreement with Emcure Pharmaceuticals for its oral anti-diabetic portfolio, including popular brands like Amaryl® and Cetapin®. Sanofi will continue manufacturing these products. This partnership aims to significantly expand market penetration and reach for its vital diabetes medicines across India, leveraging Emcure's network.